Volume 87, Issue 5, 2022-11-1, Pages A9-e203 (November)

Articles in this issue:

1. Editorial Board

2. Table of Contents

3. Information for Readers

4. JAAD Case Reports Article List

5. Journal Based CME Instructions and Information

6. Systemic sclerosis in adults. Part I: Clinical features and pathogenesis

7. Systemic sclerosis in adults. Part II: management and therapeutics

8. Letter from the editor: Diversity and inclusion in clinical trials

9. This Month in JAAD: November 2022

10. This Month in JAAD Case Reports: November 2022: Pterygium inversus unguis treated with botulinum toxin A

11. This Month in JAAD International: November 2022: Practical approaches to managing hair loss

12. Eczema knowledge gaps: Patching things up

13. First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600–mutant advanced melanoma

14. Cluster analysis reveals eosinophilia and fibrosis as poor prognostic markers in 128 patients with eosinophilic fasciitis

15. Hand eczema and temporal variation of Staphylococcus aureus clonal complexes: A prospective observational study

16. Patch testing with ammonium persulfate: The North American Contact Dermatitis Group Experience, 2015-2018

17. Medical adhesive allergens: Retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001-2018

18. Patch testing with glucosides: The North American Contact Dermatitis Group experience, 2009-2018

19. The immediate patch test reaction to fragrance in patients with allergic contact dermatitis to fragrance: A prospective study

20. Hand and foot dermatitis in patients referred for patch testing: Analysis of North American Contact Dermatitis Group Data, 2001-2018

21. Central nervous system magnetic resonance imaging abnormalities and neurologic outcomes in pediatric patients with congenital nevi: A 10-year multi-institutional retrospective study

22. Monkeypox emerges on a global scale: A historical review and dermatologic primer

23. Leveraging behavioral economics to promote treatment adherence: A primer for the practicing dermatologist

24. Review of aluminum, paraben, and sulfate product disclaimers on personal care products

25. Similar response to biologic therapy across racial and ethnic groups among patients with psoriasis enrolled in the CorEvitas Psoriasis Registry

26. An open-label phase 2a study investigating the efficacy and safety of a cathepsin S inhibitor in patients with moderate-to-severe psoriasis

27. Use of virtual reality during scalp injections: A randomized interventional crossover study

28. Frequency of immunostimulatory herbal supplement use among patients with autoimmune skin disease

29. Geographical distribution of systemic sclerosis in Canada: An ecologic study based on the Canadian Scleroderma Research Group

30. The need for potassium monitoring in women on spironolactone for dermatologic conditions

31. Risk factors for postoperative wound dehiscence after skin repair: A case-control study

32. Beliefs and barriers to care of primary care practitioners toward melanoma screening and education in rural Texas

33. Disease characteristics, comorbidities, treatment patterns and quality of life impact in children <12 years old with atopic dermatitis: Interim results from the PEDISTAD Real-World Registry

34. Workforce characteristics of nonphysician clinicians in dermatology in the United States

35. A cross-sectional analysis of quality of life in skin of color patients with cutaneous T-cell lymphoma: An exploratory study

36. Correlations between hormonal intrauterine devices and androgenic skin conditions: A retrospective cohort study

37. Merkel cell carcinoma treatment with Mohs micrographic surgery versus wide local excision: A retrospective cohort survival analysis

38. Antibiotic prophylaxis for full thickness and split thickness skin grafts in Mohs micrographic surgery: A retrospective case series and review of the literature

39. Impact of multimodal dermatoscopy training on skin biopsies by primary care providers

40. Epidemiology of alopecia areata in Black patients: A retrospective chart review

41. A retrospective study of nail squamous cell carcinoma at a single tertiary center: A relationship between longitudinal melanonychia and the depth of invasion

42. Incidence of bullous pemphigoid and risk of mortality in the dialysis population: A retrospective cohort study

43. Frequency and patterns of editorial rejections (rejections without peer review) across medical journals

44. Measuring the rate of patients’ deliberate circumvention of iPledge pregnancy testing

45. Clinical characteristics and misdiagnosis of pyoderma gangrenosum of the head and neck: A retrospective study

46. Tacrolimus “swish and spit” for complex aphthosis: Outcomes in 21 patients

47. Discoid lesions and smoking history are negative predictors of disease activity remission in cutaneous lupus erythematosus

48. A predictive system for Henoch-Schönlein purpura nephritis established by multivariate analysis plus nomogram model in Chinese hospitalized children: A retrospective cohort study

49. Acceleration of skin involvement may predict disease progression in early-stage mycosis fungoides: A retrospective cohort study

50. Assessment of adherence to skin care recommendations in clinical practice: A real-world observational study

51. Real-world experience with ustekinumab for the treatment of plaque psoriasis in pediatric patients: A retrospective, single-center chart review

52. The risk of atopic comorbidities and atopic march progression among Black and White children with mild-to-moderate atopic dermatitis: A cross-sectional study

53. Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma

54. Case/noncase analysis of the FDA Adverse Events Reporting System suggests higher reporting odds of photosensitivity and esophageal symptoms for sarecycline than of those for other tetracyclines

55. Accuracy of Medicaid physician directories of surgeons performing Mohs micrographic surgery

56. Cost effectiveness of dermatofibrosarcoma protuberans treated with Mohs micrographic surgery compared with wide local excision

57. Retrospective analysis of the MAUDE database on dermal filler complications from 2014–2020

58. Impact of electronic prescribing on issued and filled opioid prescriptions following Mohs micrographic surgery

59. Disseminated superficial porokeratosis: Impact on quality of life

60. Chemoprevention of cutaneous squamous cell carcinoma and its precursors in solid organ transplant recipients using topical sirolimus: A randomized, double-blind, placebo-controlled pilot trial

61. Cross-sectional evaluation of Spanish-language resources on websites of US dermatology organizations

62. Surgical site infections due to razor-mediated hair removal in dermatologic surgery: A retrospective cohort study

63. Financial insecurity among children with atopic dermatitis in the United States

64. Genotype-phenotype correlations of neurovascular structures on the feet in patients with pachyonychia congenita: A cross-sectional study

65. The underrepresentation of older adults in clinical trials of Janus kinase inhibitors in the treatment of atopic dermatitis

66. Management of acute, lower extremity surgical wounds using an ablative fractional laser: A single-center, randomized, double-blinded controlled trial

67. Racial and ethnic diversity in clinical trials of laser treatments for scars

68. Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report

69. A real-world, single-center experience and the immediate impact of granulocyte and monocyte adsorption apheresis on generalized pustular psoriasis

70. Association of airborne toxins with geographic clustering of cutaneous T-cell lymphoma in Louisiana

71. Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study

72. Safety, tolerability, and efficacy of a novel topical isotretinoin formulation for the treatment of X-linked or lamellar congenital ichthyosis: Results from a phase 2a proof-of-concept study

73. The value of measuring uncertainty in neural networks in dermoscopy

74. Geographic practice preferences of graduating medical students pursuing careers in dermatology

75. Incidence of childhood-onset vitiligo and increased risk of atopic dermatitis, autoimmune diseases, and psoriasis: A nationwide population-based study

76. Acne risk in transgender and gender diverse populations: A retrospective, comparative cohort study

77. Prevalence and clinical features of herpes simplex virus infection in oral lesions of pemphigus vulgaris: A prospective, cross-sectional study

78. A cross-sectional study of male balding patterns in people of color

79. Groin and buttocks involvement and methicillin-resistant Staphylococcus aureus nasal swab independently predict cutaneous abscess and methicillin-resistant Staphylococcus aureus infection in inpatient pediatric cellulitis: A retrospective cohort study

80. A randomized controlled pilot study of autoinoculation versus 35% trichloroacetic acid for the treatment of molluscum contagiosum

81. Circulating tumor DNA as a predictive biomarker in Merkel cell carcinoma

82. Treatments for calcinosis cutis in autoimmune connective tissue diseases

83. Primary Spanish speakers and sun-protective behaviors: A cross-sectional study

84. Assessing the role of stressful life events in the induction and recurrence of alopecia areata: A case-control study

85. Delays in melanoma presentation during the COVID-19 pandemic: A nationwide multi-institutional cohort study

86. A health equity framework to address racial and ethnic disparities in melanoma

87. Dermatology in orbit: Anticipating skin care requirements in the space age

88. The Supreme Court abortion ban impact on dermatology

89. The effects of 35% trichloroacetic acid-Croton oil and 35% glycolic acid-Croton oil compared to 35% phenol-Croton oil Hetter’s very heavy formula for deep chemical peel

90. Unpaid research fellowships among dermatology residency applicants

91. Beyond JAAD: Articles of interest to dermatologists from the nondermatologic literature

92. JAAD Game Changers∗: Longitudinal atopic dermatitis control and persistence vary with timing of disease onset in children: A cohort study

93. JAAD Game Changers∗: Inflammatory arthritis in pediatric patients with morphea

94. Pinch and stretch test to assess and categorize the severity of acne rolling scars

95. A simple, inexpensive, and reproducible wound dressing to optimize topical drug absorption after ablative fractional laser-assisted drug delivery

96. Hold firmly, coagulate indirectly, and pull gently: A simple and swift technique for radiofrequency-assisted removal of small benign skin lesions

97. Office-based surgical treatment of hidradenitis suppurativa: The unroofing technique

98. A new suture technique for flap closure in dermatologic surgery

99. The use of a portable black light (UV-A) flashlight to aid in biopsy site identification

100. Converting a next-generation digital light microscope to a dark-field microscope

101. Reply to “Correlation of Basal Cell Carcinoma Subtype With Histologically Confirmed Subclinical Extension During Mohs Micrographic Surgery: A Prospective Multi-Center Study”

102. It is all alopecia areata: It is time to abandon the terms alopecia totalis and alopecia universalis

103. Disability inclusion in dermatologic research: Response to “Lifetime history of total body skin examinations in patients with disabilities: Examining for differences in skin cancer screening”

104. Improving access to dermatologic care for patients with mobility-related disabilities

105. From the Cochrane Library: Interventions for the prevention of recurrent erysipelas and cellulitis

106. Strategies for augmenting the Spanish-speaking dermatology workforce of the United States

107. Reply to letter to the editor

108. Comment on “Guidelines of care for the management of actinic keratosis”

109. Significant improvement of facial actinic keratoses after blue light photodynamic therapy with oral vitamin D pretreatment

110. Response to the article, “Evaluation of standardized scalp photography on patient perception of hair loss severity, anxiety, and treatment,” by Pathoulas et al

111. Reply to “Response to Pathoulas et al’s ‘Evaluation of standardized scalp photography on patient perception of hair loss severity, anxiety, and treatment’”

112. Current outbreak of monkeypox: Essentials for the dermatologist

113. Comments on “Bullous pemphigoid: Three main clusters defining 3 outcome profiles”

114. Diagnosis of stress-associated dermatologic conditions in New York City safety-net hospitals during the COVID-19 pandemic

115. Dermatologic care for patients with mobility-related disabilities

116. From the Cochrane library: Oral treatments for fungal infections of the skin of the foot

117. Glutaraldehyde sensitization does not explain reactivity to alkyl polyglucosides in personal care products: Results from review of a large contact allergy database

118. Developing and implementing approaches to limit antimicrobial resistance

119. Reducing language barriers in dermatology: A step toward equitable care

120. Moving toward a holistic dermatology application process: Importance of holistic review of applicant research output

121. Underrepresentation of skin of color in dermatology grand rounds cases: A single-center retrospective study

122. Comment on “Antibiotic Resistance in Dermatology: The Scope of the Problem and Strategies to Address It”

123. Response to Fulk et al’s “Geographic practice preferences of graduating medical students pursuing careers in dermatology”

124. Response to “Response to Fulk et al’s ‘Geographic practice preferences of graduating medical students pursuing careers in dermatology’”

125. Standardized guidelines for acral and nail unit melanoma treatment are lacking

126. Dermatology essentials, Second edition